financetom
Business
financetom
/
Business
/
Home Depot beats quarterly sales estimates on stable demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Home Depot beats quarterly sales estimates on stable demand
May 26, 2025 10:42 AM

(Reuters) -Home Depot ( HD ) beat Wall Street estimates for first-quarter sales on Tuesday as the world's largest home improvement retailer enjoyed resilient demand from professional contractors and small-scale repair works by existing homeowners.

The Atlanta-based retailer has benefited from demand for tools used in do-it-yourself house projects, repair and maintenance ahead of the spring season, even as budget constraints weighed on larger home renovation activities.

Home Depot ( HD ) has also capitalized on demand from its professional customer base, including contractors, by increasing investment in its supply chain after acquiring Texas-based SRS Distribution last year.

The retail chain kept its fiscal year 2025 forecast unchanged, with a total sales growth target of 2.8%. Shares of the company were up about 2% in premarket trading.

"....We saw continued customer engagement across smaller projects and in our spring events," CEO Ted Decker said in a statement.

The company posted net sales of $39.86 billion for the quarter ended May 4, a 9% jump from last year. Analysts on average had expected an 8% rise to $39.31 billion, according to data compiled by LSEG.

(Reporting by Savyata Mishra in Bengaluru; Editing by Devika Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nature's Miracle Holding Inc. Secures $5 Million Loan Backed by Ohio Property
Nature's Miracle Holding Inc. Secures $5 Million Loan Backed by Ohio Property
Mar 11, 2026
ONTARIO, Calif., Feb. 2, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. has finalized a $5 million loan with an institutional lender for its Toledo, Ohio commercial office property, owned through subsidiary Zak Properties LLC. The loan features an 8.5% interest rate, a two-year term, and includes an optional one-year extension. Funds from the loan will be used to pay off...
Yext CEO Withdraws Non-Binding Acquisition Proposal; Company Intends to Repurchase $150 Million of Common Stock Through Self-Tender Offer
Yext CEO Withdraws Non-Binding Acquisition Proposal; Company Intends to Repurchase $150 Million of Common Stock Through Self-Tender Offer
Mar 11, 2026
NEW YORK--(BUSINESS WIRE)-- Yext, Inc. ( YEXT ) , the leading brand visibility platform, today announced that Michael Walrath, its Chief Executive Officer and Chairman of the Board of Directors, has withdrawn his previously announced proposal to acquire all outstanding shares of the Company not already owned by him at a price of $9.00 per share in cash. Mr. Walrath...
Park National Bank announces completion of First Citizens National Bank merger
Park National Bank announces completion of First Citizens National Bank merger
Mar 11, 2026
NEWARK, Ohio and DYERSBURG, Tenn., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Park National Corporation ( PRK ) (“Park”) announced that on February 1, 2026, it successfully completed its previously announced merger transaction with First Citizens Bancshares, Inc. (“First Citizens”) (OTCEM: FIZN) through an all-stock transaction. The merger combines two strong community-focused bank subsidiaries – Park National Bank and First Citizens...
Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”
Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”
Mar 11, 2026
PARAMUS, NJ, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics ( PLYX ) (“Polaryx” or the “Company”) a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announced that shares of the Company’s common stock will start trading today on the Nasdaq Capital Market (“Nasdaq”) under the ticker...
Copyright 2023-2026 - www.financetom.com All Rights Reserved